We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Marcus & Millichap
MMI
$1.17B
| $1.08M | 0.01% |
+28,700
| New | +$1.02M |
|
|
LVLT
702
DELISTED
Level 3 Communications Inc
LVLT
| $1.07M | 0.01% |
+19,958
| New | +$1.04M |
|
|
NCI
703
DELISTED
Navigant Consulting, Inc.
NCI
| $1.07M | 0.01% |
82,530
+42,050
| +104% | +$596K |
|
704
Chunghwa Telecom
CHT
$32.8B
| $1.05M | 0.01% |
+32,844
| New | +$1.01M |
|
705
Zions Bancorporation
ZION
$10.3B
| $1.05M | 0.01% |
38,943
-144,271
| -79% | -$3.78M |
|
|
CAVM
706
DELISTED
Cavium, Inc.
CAVM
| $1.05M | 0.01% |
+14,818
| New | +$962K |
|
707
Agios Pharmaceuticals
AGIO
$1.94B
| $1.05M | 0.01% |
+11,100
| New | +$1.24M |
|
|
CHK
708
DELISTED
Chesapeake Energy Corporation
CHK
| $1.04M | 0.01% |
368
+178
| +94% | +$628K |
|
709
UDR
UDR
$12.1B
| $1.04M | 0.01% |
30,458
-31,513
| -51% | -$1.04M |
|
710
Foster
FSTR
$420M
| $1.01M | 0.01% |
21,252
| – | – |
|
|
HAWK
711
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $1.01M | 0.01% |
+28,311
| New | +$1.01M |
|
712
Affiliated Managers Group
AMG
$9.77B
| $999K | 0.01% |
+4,650
| New | +$981K |
|
|
BHI
713
DELISTED
Baker Hughes
BHI
| $998K | 0.01% |
15,700
+3,353
| +27% | +$202K |
|
714
Saic
SAIC
$5.33B
| $988K | 0.01% |
19,236
-5,536
| -22% | -$290K |
|
715
Vera Bradley
VRA
$97.5M
| $988K | 0.01% |
60,854
+32,565
| +115% | +$600K |
|
716
Lincoln Electric
LECO
$15.3B
| $987K | 0.01% |
15,100
+10,641
| +239% | +$721K |
|
|
FLY
717
DELISTED
Fly Leasing Limited
FLY
| $987K | 0.01% |
67,804
| – | – |
|
|
DISH
718
DELISTED
DISH Network Corp.
DISH
| $984K | 0.01% |
14,046
-6,833
| -33% | -$504K |
|
719
CBIZ
CBZ
$2.96B
| $980K | 0.01% |
105,015
-73,484
| -41% | -$643K |
|
720
Oil States International
OIS
$518M
| $978K | 0.01% |
+24,600
| New | +$1.04M |
|
|
ANAT
721
DELISTED
American National Group, Inc. Common Stock
ANAT
| $974K | 0.01% |
9,895
| – | – |
|
722
EPR Properties
EPR
$4.68B
| $972K | 0.01% |
16,190
-43,648
| -73% | -$2.68M |
|
723
ArcBest
ARCB
$3.12B
| $965K | 0.01% |
25,467
+13,014
| +105% | +$526K |
|
724
Hershey
HSY
$36.4B
| $962K | 0.01% |
+9,529
| New | +$994K |
|
|
GTI
725
DELISTED
GRAFTECH INTERNATIONAL LTD
GTI
| $960K | 0.01% |
+246,805
| New | +$990K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.